Insider Trading Alert - ENTA, CIEN And NGL Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Sept. 16, 2014, 80 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $235.26 to $11,203,447.50.

Highlighted Stocks Traded by Insiders:

Enanta Pharmaceuticals (ENTA) - FREE Research Report

Mellett Paul J, who is Treasurer and CFO at Enanta Pharmaceuticals, sold 10,000 shares at $39.83 on Sept. 16, 2014. Following this transaction, the Treasurer and CFO owned 136,397 shares meaning that the stake was reduced by 6.83% with the 10,000-share transaction.

The shares most recently traded at $39.84, up $0.01, or 0.02% since the insider transaction. Historical insider transactions for Enanta Pharmaceuticals go as follows:

  • 4-Week # shares bought: 1,000
  • 4-Week # shares sold: 10,000
  • 12-Week # shares bought: 1,000
  • 12-Week # shares sold: 40,000
  • 24-Week # shares bought: 1,000
  • 24-Week # shares sold: 50,000

The average volume for Enanta Pharmaceuticals has been 232,900 shares per day over the past 30 days. Enanta Pharmaceuticals has a market cap of $743.1 million and is part of the health care sector and drugs industry. Shares are up 45.97% year-to-date as of the close of trading on Tuesday.

Enanta Pharmaceuticals, Inc., a biotechnology company, is engaged in the development of small molecule drugs for the infectious disease field. The company has a P/E ratio of 23.7. Currently, there are 3 analysts who rate Enanta Pharmaceuticals a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ENTA - FREE

TheStreet Quant Ratings rates Enanta Pharmaceuticals as a hold. The company's strengths can be seen in multiple areas, such as its notable return on equity, robust revenue growth and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we find that the growth in the company's earnings per share has not been good. Get the full Enanta Pharmaceuticals Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Ciena (CIEN) - FREE Research Report

Alexander Stephen B, who is Sr VP Chief Technology Officer at Ciena, sold 3,500 shares at $19.41 on Sept. 16, 2014. Following this transaction, the Sr VP Chief Technology Officer owned 159,597 shares meaning that the stake was reduced by 2.15% with the 3,500-share transaction.

The shares most recently traded at $19.28, down $0.13, or 0.67% since the insider transaction. Historical insider transactions for Ciena go as follows:

  • 4-Week # shares sold: 1,000
  • 12-Week # shares sold: 15,500
  • 24-Week # shares sold: 104,409

The average volume for Ciena has been 3.0 million shares per day over the past 30 days. Ciena has a market cap of $2.0 billion and is part of the technology sector and telecommunications industry. Shares are down 20.14% year-to-date as of the close of trading on Tuesday.

Ciena Corporation provides communications networking equipment, software, and services that support the transport, switching, aggregation, and management of voice, video, and data traffic worldwide. Currently, there are 14 analysts who rate Ciena a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CIEN - FREE

TheStreet Quant Ratings rates Ciena as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, impressive record of earnings per share growth and compelling growth in net income. However, as a counter to these strengths, we find that the stock has had a generally disappointing performance in the past year. Get the full Ciena Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

NGL Energy Partners (NGL) - FREE Research Report

Kehoe David C, who is Exec. VP NGL Crude Logistics at NGL Energy Partners, sold 14,455 shares at $42.79 on Sept. 16, 2014. Following this transaction, the Exec. VP NGL Crude Logistics owned 186,630 shares meaning that the stake was reduced by 7.19% with the 14,455-share transaction.

The shares most recently traded at $41.63, down $1.16, or 2.79% since the insider transaction. Historical insider transactions for NGL Energy Partners go as follows:

  • 4-Week # shares sold: 110,545
  • 12-Week # shares sold: 1.6 million
  • 24-Week # shares sold: 1.6 million

The average volume for NGL Energy Partners has been 341,600 shares per day over the past 30 days. NGL Energy Partners has a market cap of $3.5 billion and is part of the basic materials sector and energy industry. Shares are up 20.29% year-to-date as of the close of trading on Tuesday.

NGL Energy Partners LP, through its subsidiaries, is primarily engaged in the crude oil logistics, water solutions, liquids, and retail propane businesses in the United States. It operates through Crude Oil Logistics, Water Solutions, Liquids, and Retail Propane segments. The stock currently has a dividend yield of 5.67%. The company has a P/E ratio of 166.2. Currently, there are 5 analysts who rate NGL Energy Partners a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on NGL - FREE

TheStreet Quant Ratings rates NGL Energy Partners as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and poor profit margins. Get the full NGL Energy Partners Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

Flashback Friday: The Market Movers

Flashback Friday: The Market Movers

OPEC Deal Doesn't Boost Production Enough to Drive Down Crude, Gasoline Prices

OPEC Deal Doesn't Boost Production Enough to Drive Down Crude, Gasoline Prices